Literature DB >> 24701473

Effect of Smoking on Metalloproteinases (MMPs) Activity in Patients with Acute Myocardial Infarction (AMI).

Sreekanth K Sivaraman1, Geevar Zachariah2, Pt Annamala3.   

Abstract

INTRODUCTION: Many risk factors are involved in the course and pathogenesis of Acute Myocardial Infarction (AMI). Smoking can significantly increase the AMI mortality and morbidity. Matrix metalloproteinases (MMPs), a class of Zn containing enzymes, are involved in the erosion of the fibrous cap and rupture of the plaque which leads to AMI. AIM: To evaluate the activity of MMP2 and MMP9 in AMI patients, with or without the habit of smoking.
MATERIALS AND METHODS: The study group consists of 300 AMI patients and 100 sex and age matched control subjects with and without the habit of smoking. MMP2 and MMP9 activities were measured in the blood samples of these patients and controls by sandwich enzyme immunoassay and the values were noted and compared.
RESULTS: Both MMP2 and MMP9 were found to be significantly elevated in all the AMI patients when compared to the normal controls subjects irrespective of the habit of smoking. However MMP9 showed a significant elevation when compared to MMP2 in patients with the habit of smoking.
CONCLUSION: The results of the present study shows increased concentration of both MMPs in AMI patients. However, concentration of MMP9 was found to be more in patients with the habit of smoking when compared to MMP2, indicating that smoking can increase the activity of MMP9 in these patients. Hence apart from producing the free radicals, the smoke can increase the activities of matrix degrading enzymes which in turn contribute to the vulnerability of plaque.

Entities:  

Keywords:  Acute Myocardial Infarction; Matrix Metalloproteinases

Year:  2014        PMID: 24701473      PMCID: PMC3972584          DOI: 10.7860/JCDR/2014/7052.3998

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  29 in total

Review 1.  Atherosclerosis is an inflammatory disease.

Authors:  R Ross
Journal:  Am Heart J       Date:  1999-11       Impact factor: 4.749

2.  Coronary heart disease: epidemiology of smoking and intervention studies of smoking.

Authors:  L Wilhelmsen
Journal:  Am Heart J       Date:  1988-01       Impact factor: 4.749

3.  Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.

Authors:  S W Galt; S Lindemann; D Medd; L L Allen; L W Kraiss; E S Harris; S M Prescott; T M McIntyre; A S Weyrich; G A Zimmerman
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

4.  Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics.

Authors:  K Yano; D M Reed; D L McGee
Journal:  Am J Epidemiol       Date:  1984-05       Impact factor: 4.897

5.  Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.

Authors:  E Lutgens; K B Cleutjens; S Heeneman; V E Koteliansky; L C Burkly; M J Daemen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.

Authors:  Y Inokubo; H Hanada; H Ishizaka; T Fukushi; T Kamada; K Okumura
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

7.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

Authors:  K D O'Brien; M D Allen; T O McDonald; A Chait; J M Harlan; D Fishbein; J McCarty; M Ferguson; K Hudkins; C D Benjamin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Antioxidant activity of Smoke Shield in-vitro and in-vivo.

Authors:  Kavitha Sivaraman Sreekanth; Mandumpal Chacko Sabu; Leyon Varghese; Chittezhath Manesh; Girija Kuttan; Ramadasan Kuttan
Journal:  J Pharm Pharmacol       Date:  2003-06       Impact factor: 3.765

9.  Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells.

Authors:  Hsuan-Hsu Chen; Danny Ling Wang
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

10.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

Authors:  Z S Galis; G K Sukhova; R Kranzhöfer; S Clark; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

View more
  4 in total

Review 1.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

2.  Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Authors:  David M Thompson; Hsi-Ming Lee; Julie A Stoner; Lorne M Golub; Pirkka V Nummikoski; Jeffrey B Payne
Journal:  J Periodontal Res       Date:  2019-04-29       Impact factor: 4.419

3.  Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer.

Authors:  Yasuyoshi Miyata; Kensuke Mitsunari; Asai Akihiro; Shin-Ichi Watanabe; Yasushi Mochizuki; Hideki Sakai
Journal:  Mol Clin Oncol       Date:  2014-12-02

4.  Opioid Use Disorder Induces Oxidative Stress and Inflammation: The Attenuating Effect of Methadone Maintenance Treatment.

Authors:  Ali Salarian; Mehri Kadkhodaee; Maryam Zahmatkesh; Behjat Seifi; Enayatollah Bakhshi; Shahin Akhondzadeh; Soheila Adeli; Hassan Askari; Mohammad Arbabi
Journal:  Iran J Psychiatry       Date:  2018-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.